Prescription Drugs Market Research Reports & Industry Analysis
The prescription drugs industry is a key cornerstone of healthcare, delivering vital medications that improve and save lives. As this industry continues to evolve, understanding its nuances can be an ongoing challenge. MarketResearch.com provides hundreds of authoritative prescription drugs market research reports to help stakeholders understand the shifting market landscape and devise effective business strategies.
The Latest Prescription Drugs Market Analysis
- We provide data-packed reports on a wide range of product types, therapeutic areas, regions, and companies.
- Our research includes in-depth analyses of prescription drug market size, growth forecasts, and drivers and challenges.
- In addition, we cover the rise of personalized medicine and gene therapies, as well as regulatory issues and pricing models.
Your Dedicated Research Partner
As the prescription drugs industry shifts and changes, MarketResearch.com equips you with the tools to thrive. Trusted for decades as a reliable research partner, our clients include top pharmaceutical companies, investment banks, and universities. Whether you are exploring new markets or seeking to futureproof your business, our prescription drugs industry research reports offer a wealth of knowledge to inform your strategy. Get started by exploring our vast selection of reports on the prescription drugs industry today.
Prescription Drugs Industry Research & Market Reports
-
European Online Pharmacy Market: Analysis By Type (OTC and Rx), By Region Size And Trends With Impact Of COVID-19 And Forecast up to 2027
... 2021 and is expected to reach US$44.18 billion by 2027. An online pharmacy is a website offering to deliver, distribute or dispense medication on the internet directly to consumers. The online pharmacy market is a ... Read More
-
Type 2 Diabetes Treatment: Global Market Outlook
... 2 diabetes treatment market and analyses market trends. Using 2021 as the base year, it provides estimated market data for the forecast period of 2022 to 2027. Revenue forecasts for this period are segmented based ... Read More
-
Pharmaceuticals and Medical Equipment in Asia Pacific
... expected to record the fastest production growth globally, underpinned by its sizeable population, expanding access to healthcare, improving business environment and major investments into research and development. The Pharmaceuticals and Medical Equipment in Asia Pacific ... Read More
-
Global Atopic Dermatitis Treatment Market 2022-2028
... the latest edition of the Global Atopic Dermatitis Treatment Market Report. The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global atopic dermatitis treatment market. It traces the ... Read More
-
Restless Leg Syndrome Market 2022-2028
... a key factor responsible for the growth of the market. RLS is a disorder that is associated with the part of the nervous system that causes patients an urge to move the legs restlessly. According ... Read More
-
Ophthalmic Drugs and Devices Market—Forecast till 2030
... cleaning, specialist contact lenses, and other tools. The global market for ophthalmic medications and equipment is being driven by reasons like a growing older population, rising diabetes occurrences, and a growing prevalence of ocular diseases. ... Read More
-
Retina Health Market Forecast till 2030
... the back of the eye that transforms light entering the eye into electrical signals that the brain may process into images. The prevention of vision problems and even blindness depends on a healthy retina. The ... Read More
-
Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormones, Cytokines), Drug (OTC,Rx) Application (Diabetes, Oncology, CVD) - Global Forecast to 2027
... market is estimated to reach USD 145.9 billion by 2022 to USD 216.4 billion in 2027, at a CAGR of 8.2% during the forecast period. Factors such as the increasing uptake of biopharmaceuticals, the growing ... Read More
-
JEMPERLI (dostarlimab) Drug Insight and Market Forecast – 2032
... picture of the JEMPERLI (dostarlimab) for Metastatic Colorectal Cancer in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this ... Read More
-
KEYTRUDA (pembrolizumab) Drug Insight and Market Forecast – 2032
... picture of the KEYTRUDA (pembrolizumab) for Metastatic Colorectal Cancer in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this ... Read More
-
Abrocitinib Market Drug Insight and Market Forecast − 2032
... picture of the abrocitinib for atopic dermatitis in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report ... Read More
-
Braftovi (encorafenib) + Erbitux (cetuximab) ± Mektovi (binimetinib) Emerging Drug Insight and Market Forecast – 2032
... insights about Braftovi (encorafenib) + Erbitux (cetuximab) ± Mektovi (binimetinib) for Metastatic Colorectal Cancer (mCRC) in the 7MM. A detailed picture of the Braftovi (encorafenib) + Erbitux (cetuximab) ± Mektovi (binimetinib) for Metastatic Colorectal Cancer ... Read More
-
TYVASO Drug Insight and Market Forecast – 2032
... for Pulmonary Arterial Hypertension in the 6MM, i.e., United States, and EU5 (Germany, France, Italy, Spain, and the United Kingdom), for the study period 2019–2032 is provided in this report along with a detailed description ... Read More
-
KY1005 Emerging Drug Insight and Market Forecast − 2032
... picture of the KY1005 for atopic dermatitis in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report ... Read More
-
OXLUMO Market Drug Insight and Market Forecast − 2032
... picture of the OXLUMO for primary hyperoxaluria in the 7MM, i.e., United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, and Japan, for the study period 2019 –2032 is provided in this report along ... Read More
-
RINVOQ Drug Insight and Market Forecast – 2032
... Rheumatoid Arthritis in the 7MM, i.e., United States, EU4 (Germany, France, Italy, Spain), and the United Kingdom, and Japan for the study period 2019–2032 is provided in this report along with a detailed description of ... Read More
-
EYLEA Market Drug Insight and Market Forecast − 2032
... of the EYLEA for diabetic retinopathy in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this ... Read More
-
Inavolisib Emerging Drug Insight and Market Forecast – 2032
... detailed picture of the Inavolisib for ER+ve HER2-ve Breast Cancer in the United States for the study period 2019–2032 is provided in this report along with a detailed description of the Inavolisib for ER+ve HER2-ve ... Read More
-
MIN-102 Emerging Drug Insight and Market Forecast – 2032
... for Adrenoleukodystrophy in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed description of ... Read More
-
Tradipitant Emerging Drug Insight and Market Forecast − 2032
... picture of the tradipitant for atopic dermatitis in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report ... Read More
-
Pridopidine Emerging Drug Insight and Market Forecast – 2032
... Pridopidine for Huntington’s disease in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the UK, and Japan, for the study period 2019–2032 is provided in this report along with a ... Read More
-
SOM3355 Emerging Drug Insight and Market Forecast – 2032
... SOM3355 for Huntington’s disease in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the UK, and Japan, for the study period 2019–2032 is provided in this report along with a ... Read More
-
VRAYLAR Market Drug Insight and Market Forecast – 2032
... of the VRAYLAR for Bipolar Depression in the United States for the study period 2019 –2032 is provided in this report along with a detailed description of the VRAYLAR for Bipolar Depression. The report provides ... Read More
-
CIMZIA Drug Insight and Market Forecast – 2032
... Rheumatoid Arthritis in the 7MM, i.e., United States, EU4 (Germany, France, Italy, and Spain), and the United Kingdom, and Japan for the study period 2019–2032 is provided in this report along with a detailed description ... Read More
-
SIMPONI Drug Insight and Market Forecast – 2032
... Rheumatoid Arthritis in the 7MM, i.e., United States, EU4 (Germany, France, Italy, and Spain), and the United Kingdom, and Japan for the study period 2019–2032 is provided in this report along with a detailed description ... Read More
Research Assistance
